Welcome to MOPEAD

The MOPEAD project is designed to assess different Patient Engagement models across Europe, to identify efficient approaches of earlier identification of mild AD dementia and prodromal AD patients.

Please reload

Our Goal

MOPEAD has the potential to contribute to move the AD Environment towards earlier diagnosis to improve identification of appropriate patients for disease modifying therapies. 

MOPEAD Materials on Alzheimer's disease and dementia

Want to know more about why your memory matters? Read our brochures and infographics on normal ageing vs dementia, the importance of timely diagnosis and common risk factors for Alzheimer's Disease as well as some tips for coping with memory loss.  

Subscribe to Our Newsletter

Our Videos

The MOPEAD team have developed a range of videos which explain why your memory health is important and how the project works. 

Follow us

  • Facebook
  • Twitter
  • YouTube

©2019 MOPEAD

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under Grant Agreement No 115985. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations